| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Teleselling > No More Cold-Calling? Well, Almost... |
|
Digg It - No More Cold-Calling? Well, Almost...
We do not advocate cold calling in High Probability Selling.
However, cold calling is necessary at times. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product You do need prospective clients and customers: If you don't have a customer list from which to solicit ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in referrals, and you also lack an advertising/marketing budget, cold-calling to a highly targeted list is th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e fastest route to finding High Probability Prospects. A High Probability Prospect is one who wants, need here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s, can afford,
and is ready to buy your product or service- now. Those who only
want, need, and can affo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rd- but are not ready to buy now- are
prospects that you'll continue to contact in the future. How does ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Cold Calling fit into High Probability Prospecting? When you start to call your list, initial contacts wi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ll be cold calls: Only first-time calls are cold calls in High Probability Prospecting. A truly effective nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically prospecting campaign requires that you call the same list every 3 to 4 weeks, so after a short period of t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ime, most of your calls will be warm calls. A higher percentage of the people on your list will say "Yes" ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi to your prospecting offer with each successive call. 5 Simple rules for maximum effectiveness and maximum ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a efficiency:
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod >
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin its features.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n prospects say "No," you say, "Okay, good-bye."
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel /OL> With practice, you should be able to make at least 50 dials per hour. You'll find an increasing numb ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust er of High Probability Prospects with each pass through your list. You'll be on your way to making appoint y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ments with people who are ready to buy what you're selling- right now. High Probability Prospecting won't . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de eliminate cold-calling entirely. You will, however, be making relatively fewer Cold Calls. You'll also el elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip iminate most of the Rejection associate with cold-calling. High Probability® Selling ©All Rights Reserve tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Wasting Your Marketing - Three Easy Ways
|